Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

New study shows efficacy of Ebola vaccine in offering protection against disease

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine.

26 Dec 2016

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Ionis Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has approved SPINRAZATM (nusinersen) under Priority Review for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.

26 Dec 2016

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.

23 Dec 2016

MDA celebrates FDA approval of new spinal muscular atrophy drug

The Muscular Dystrophy Association today celebrated news of the U.S. Food and Drug Administration's decision to grant approval for nusinersen (brand name Spinraza), the first disease-modifying drug to treat the most common genetic cause of death in infants.

23 Dec 2016

Study examines mechanisms for measuring and reporting postoperative infection complications

How do medical professionals determine whether or not a patient has experienced a post-operative complication? A team of Mayo Clinic physicians and researchers has published results of a three-year study examining mechanisms for measuring and reporting postoperative infection complications.

23 Dec 2016

Cedars-Sinai expert explains how to recognize signs and symptoms of stroke during the holidays

Along with increased cheer and festivities during the holidays comes an increased risk of stroke, one of the leading causes of death and disability in the U.S.

23 Dec 2016

TSRI scientists shed light on how antiviral drug stops influenza infections

A new study led by scientists at The Scripps Research Institute (TSRI) is the first to show exactly how the drug Arbidol stops influenza infections. The research reveals that Arbidol stops the virus from entering host cells by binding within a recessed pocket on the virus.

22 Dec 2016

Researchers engineer promising live-attenuated RSV vaccine candidate

Crafting a vaccine against RSV (respiratory syncytial virus) has been a minefield for 50 years, but scientists believe they have found the right balance.

21 Dec 2016

TPC toxicologists warn about hidden dangers of button batteries to children

Button batteries are small round batteries found in items such as toys, greeting cards, watches, hearing aids, games and flashing jewelry—all products in the average American household during the holiday season.

20 Dec 2016

Texas A&M specialist explains what people need to know about mumps

Mumps may seem like a contagion relegated to history books, but like many other diseases of the past now preventable with a vaccine, mumps has been making a resurgence.

20 Dec 2016

Texas A&M professor shares tips to protect infants from RSV

Coughing, sneezing and a runny nose: You might think it is yet another cold, but if your baby is under 2 years old, it could very well be respiratory syncytial virus (RSV).

20 Dec 2016

ANTRUK's new research finds promising leads to combat antibiotic resistance

Antibiotic resistant infections are predicted to lead to 10 million deaths per year globally by 2050 at a cost of up to $100 trillion to the world economy. In the UK, at least 5,000 people per year die from resistant infections.

20 Dec 2016

How can we tackle antimicrobial resistance?

Antimicrobial resistance happens when bugs, like bacteria, fungi or viruses, change, or evolve, when they’re exposed to drugs, like antibiotics, antifungals, or antivirals. Bugs that develop antimicrobial resistance are sometimes referred to as ‘superbugs’.

20 Dec 2016